Open Access

Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling

  • Authors:
    • Dongyue Wang
    • Yajuan Weng
    • Shuyu Guo
    • Yuxin Zhang
    • Tingting Zhou
    • Mengnan Zhang
    • Lin Wang
    • Junqing Ma
  • View Affiliations

  • Published online on: November 16, 2017     https://doi.org/10.3892/ijmm.2017.3258
  • Pages: 729-738
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Platelet-rich plasma (PRP) is used in the clinic as an autologous blood product to stimulate bone regeneration and chondrogenesis. Numerous studies have demonstrated that PRP affects bone remodeling by accelerating osteoblast formation. With the research perspective focusing on osteoclasts, the present study established a mouse model of mandibular advancement to examine the effect of PRP on osteoclast differentiation induced by modification of the dynamics of the temporomandibular joint (TMJ). The lower incisors of the mice were trimmed by 1 mm and the resultant change in mandibular position during the process of eating induced condylar adaptation to this change. PRP significantly increased the bone mass and decreased osteoclastic activity, in vitro as well as in vivo. Mechanistically, the reduced expression of receptor activator of nuclear factor-κB ligand (RANKL)‑induced differentiation marker genes, including nuclear factor of activated T-cells, cytoplasmic 1, c-fos and tartrate-resistant acid phosphatase, and that of the resorptive activity marker genes such as cathepsin k, carbonic anhydrase 2 and matrix metalloproteinase 9, indicated that PRP suppresses RANKL-induced osteoclast differentiation. A microarray analysis revealed that several genes associated with the Wnt pathway were differentially expressed, which indicated the involvement of this pathway in osteoclast differentiation. Furthermore, the activation of the Wnt pathway was verified by reverse transcription-quantitative polymerase chain reaction and immunoblot analysis of Dickkopf-related protein 1 and β-catenin. The results of the present study indicated that PRP inhibits osteoclast differentiation through activation of the Wnt pathway.
View Figures
View References

Related Articles

Journal Cover

February-2018
Volume 41 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang D, Weng Y, Guo S, Zhang Y, Zhou T, Zhang M, Wang L and Ma J: Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling. Int J Mol Med 41: 729-738, 2018
APA
Wang, D., Weng, Y., Guo, S., Zhang, Y., Zhou, T., Zhang, M. ... Ma, J. (2018). Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling. International Journal of Molecular Medicine, 41, 729-738. https://doi.org/10.3892/ijmm.2017.3258
MLA
Wang, D., Weng, Y., Guo, S., Zhang, Y., Zhou, T., Zhang, M., Wang, L., Ma, J."Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling". International Journal of Molecular Medicine 41.2 (2018): 729-738.
Chicago
Wang, D., Weng, Y., Guo, S., Zhang, Y., Zhou, T., Zhang, M., Wang, L., Ma, J."Platelet-rich plasma inhibits RANKL-induced osteoclast differentiation through activation of Wnt pathway during bone remodeling". International Journal of Molecular Medicine 41, no. 2 (2018): 729-738. https://doi.org/10.3892/ijmm.2017.3258